Therapeutic Interchange Evaluation of HMG-CoA Reductase Inhibitors in Patients with Dyslipidemia
碩士 === 臺北醫學大學 === 藥學系 === 94 === Objective: Therapeutic interchange of HMG-CoA reductase inhibitors was implemented since June 6th, 2005. Atorvastatin (Lipitor®), simvastatin (Zocor®), pravastatin (Mevalotin®) and fluvastatin (Lescol®) were substituted with simvastatin (Zolotin®) and atorvastatin (L...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2006
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/62140259769820182115 |